Skip to Main Content

Author Details

Anthony J Iafrate
Massachusetts General Hospital
1997
311
103
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37922440Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.JCO Oncol Pract2024
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
37561981The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.JCO Precis Oncol2023
38019932T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.Sci Transl Med2023
37771083Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.Histopathology2023
37322121The NCI-MATCH trial: lessons for precision oncology.Nat Med2023
37390098Prognostic biomarkers for survival in mucosal melanoma.Pigment Cell Melanoma Res2023
37318638Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.Breast Cancer Res Treat2023
37080924Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.Head Neck2023
37146750Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.J Thorac Oncol2023
37040087Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.J Natl Cancer Inst2023
37141550A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.JCO Precis Oncol2023
37437144BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.N Engl J Med2023
36520425Detection and Monitoring of Circulating Tumor HPV DNA in HPV-Associated Sinonasal and Nasopharyngeal Cancers.JAMA Otolaryngol Head Neck Surg2023
36882240Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.BMJ Open2023
36792425Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies.Clin Lung Cancer2023
34338561Mammary-type Myofibroblastoma with Leiomyomatous Differentiation: A Rare Variant with Potential Pitfalls.Int J Surg Pathol2022
35587156Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.Virulence2022
35364034T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35852437Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.Oncologist2022
35457138Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.Int J Mol Sci2022
35982179Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma.Nat Cancer2022
36051470Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.Ther Adv Med Oncol2022
34888672Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.J Infect Dis2022
34857594Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer.Clin Cancer Res2022
34995482mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.Cell2022
35202566T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35139236Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.Cancer2022
35165059Detection of EWSR1 fusions in CCOC by targeted RNA-seq.Oral Surg Oral Med Oral Pathol Oral Radiol2022
35018386T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.medRxiv2022
34587239t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.Blood Adv2022
34726838Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.Cancer Cytopathol2022
34752147Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.J Clin Oncol2022
34838892Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy.Radiother Oncol2022
33258912Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay.Am J Clin Pathol2021
33743213Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021
33619506Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.medRxiv2021
33564784Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates.medRxiv2021
33618057Nanopore Flongle Sequencing as a Rapid, Single-Specimen Clinical Test for Fusion Detection.J Mol Diagn2021
33504549Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer.Clin Cancer Res2021
33930298Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021
35122016Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations.Nat Cancer2021
34671780Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.medRxiv2021
34773119Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq.Nat Protoc2021
34101078Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA.Breast Cancer Res Treat2021
34041811Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.Oncologist2021
34265281Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.Cell2021
33316098Identification of EWSR1-NFATC2 fusion in simple bone cysts.Histopathology2021
33166549Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples.J Immunol Methods2021
33274363Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy.J Neuropathol Exp Neurol2021
  • 1 - 50 of 311

Recommended Authors

Majd Al Assaad
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2018
Number of shared co-authors 0
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 5
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 2
Malak Abedalthagafi
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 16
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 2
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 3
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2007
Number of shared co-authors 10
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 14
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year 2006
Number of shared co-authors 4
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 38
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 6
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 26
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 16
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 26
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 19
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 12
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 28
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 15
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 7
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 12
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 27
Charles Swanton
Francis Crick Institute
Career Start Year 1997
Number of shared co-authors 27
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 25
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 10
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 32
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 3
Paul T Fanta
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 4
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 7

Collaborators

Dora Dias-Santagata
Co-authored papers 60
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 51
Lecia V Sequist
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers 28
David N Louis
Co-authored papers 23
Tracy T Batchelor
Brigham and Women's Hospital
Co-authored papers 21
Andrew S Chi
Co-authored papers 19
Aditya Bardia
Massachusetts General Hospital Cancer Center
Co-authored papers 17
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Co-authored papers 17
Vivek Naranbhai
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 17
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 15
Subba R Digumarthy
Massachusetts General Hospital, USA Harvard Medical School
Co-authored papers 12
Benjamin Solomon
Peter MacCallum Cancer Centre
Co-authored papers 11
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 10
Priscilla K Brastianos
Co-authored papers 10
Cyril H Benes
Co-authored papers 9
Steven J Isakoff
Massachusetts General Hospital
Co-authored papers 9
Richelle C Charles
Massachusetts General Hospital
Co-authored papers 9
Mehmet Toner
Co-authored papers 9
Andrew E Rosenberg
Co-authored papers 8
Dennis C Sgroi
Co-authored papers 7
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Nora Horick
Massachusetts General Hospital
Co-authored papers 7
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 7
Edward T Ryan
Massachusetts General Hospital
Co-authored papers 6
Sandro Santagata
Co-authored papers 6
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 6
Rebecca A Betensky
New York University.
Co-authored papers 6
Maria Martinez-Lage
Massachusetts General Hospital
Co-authored papers 6
Patrick Y Wen
Co-authored papers 5
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Release 1.2